Today’s AI Top Pick: CSV

7/20/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Low Float Bullish Consensus Deep RotationCSVBUY NOW8.4 / 107/20/2026

Carriage Services (CSV) is the cleanest setup in the pool today because it is the only high-fundamental-score name where the tape is coiled at the bottom of its range with unanimous forecast agreement across every timeframe. Position in 21-bar range is 0% (1h), 6.87% (4h), 6.4% (1d), and 0% (1wk) — the exact opposite of chasing. Drawdown from highs is a modest -3.82% intraday and -26.64% weekly, giving you a base to buy against. Forecasts are positive on ALL 12 horizons: 1h +11.44/+13.15/+15.39%, 4h +7.16/+14.49/+15.98%, 1d +16.06/+19.19/+16.27%, and even the weekly is green (+0.51/+6.72/+3.12%). Bullish probability is 1.0 and near-term bullish score is 1.0 (the max). Fundamentals back the signal, unlike most micro-cap names in this pool that pass the low-float screen but bleed cash. CSV trades at PE 13.61 / fwd PE 10.01, ROE 17.76%, operating margin 23.47%, profit margin 10.45%, recom 1.2 (strong buy), targetUpsidePct 59.3%. Institutional ownership is 79.82% — this is a real business, not a lottery ticket. Fundamental score of 6.25 is inferior to MORN (8) and HURN (7), but both of those are pinned at 95-100% of their 1h/4h/1d ranges and MORN's 1h forecast is already turning negative (-0.65%), meaning you'd be chasing. The news tape is supportive: a July 16 quarterly cash dividend declaration and a July 7 SeekingAlpha piece titled 'Buried But Not Forgotten.' No dilution, no litigation, no guidance cut — the exact opposite of the LUCY/IPWR/PRSO/BTCT/AKTX cohort that all filed shelf/prospectus documents in the last two weeks. Why today rather than waiting: CSV is already at 0-6% of range with a -26.64% weekly drawdown, so 'waiting for a pullback' means chasing lower with no signal. The forecast tape says short-horizon moves come first (1d +16%), so the risk/reward of buying at $37.51 with a stop just below the recent low is materially better than waiting for MORN or HURN to unwind their extension.

Entry zone

$36.80–$37.75 (scale in around current $37.51; add on dips into $36.80 support)

Stop loss

$34.90 (below the recent 21-day range low and the -4.82% daily drawdown pivot)

First target

$41.50 (aligns with 1d fc_mid +19.19% and prior swing resistance)

Longer target

$47.00–$49.00 (aligns with 1d fc_long +16.27% stacked with targetUpsidePct 59.3% and recom 1.2 consensus)

Risks

Weekly chart still shows -13.47% recent momentum and -26.64% drawdown — trend has not yet turned on the higher timeframe
DebtEq 2.05 is elevated for a $598M cap consumer cyclical; a rate shock could compress the multiple
Small $598M market cap with only 3.3% short float — thin liquidity can produce sharp gaps in either direction
Sales YoY of just 1.16% means the entire thesis rests on multiple expansion, not top-line growth
Broader consumer cyclical rotation could stall if funeral services get lumped in with discretionary weakness

Honorable mentions

MORNHighest fundamental score in the pool (8) with PE 17.58, PEG 0.74, ROE 30.66% and a 1wk forecast of +13.71/+34.54/+44.97%. But it is pinned at 100% of range on 1h/4h/1d and the 1h/4h forecasts have already flattened (-0.65% / +0.51%) — better as a BUY_PULLBACK into $162-165 than a chase at $172.48.

HURNFundamental score 7, recom 1.0, targetUpsidePct 60.5%, 1d forecasts +13.09/+26.39/+27.7%. Downgraded because it sits at 100% of 1h/4h range AND the weekly forecast is outright bearish (-15.18/-12.01/-10.4%) — multi-timeframe disagreement is a yellow flag.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	CSV	BUY NOW	8.4	All 12 forecast horizons green, sitting at 0-6% of range, PE 13.6/fwdPE 10, recom 1.2, dividend just declared — cleanest low-risk entry in the pool.
2	MORN	BUY PULLBACK	7.6	Best fundamentals (score 8, PEG 0.74, ROE 30.66) with monster 1wk forecast +44.97%, but pinned at 100% of intraday range — wait for a pullback to $163-165.
3	HURN	BUY PULLBACK	6.9	Strong daily forecast (+26.39% mid) and fundamentals (recom 1, targetUpside 60.5%), but 100% of 1h/4h range and 1wk forecast is red — extension risk.
4	TASK	BUY PULLBACK	6.5	PE 5.14, fwd 3.79, ROE 26.5%, 1d fc +32/+38/+33%, but at 98.57% of 1d range and recom 2.86 is only lukewarm.
5	IDR	BUY PULLBACK	5.7	Great cashflow name (op margin 44%, sales +82.76%) at 0% of range with strong short-mid forecasts, but 1wk fc collapses to -79% — multi-TF disagreement.
6	USLM	WAIT	5.5	Great fundamentals (op margin 41.6%, profit margin 35.4%) but 1wk forecast is deeply negative (-37% long) — trend deteriorating.
7	IDN	BUY PULLBACK	5.3	At 0% of every range with fc mid +21/+41/+48%, but near_term_bullish only 0.2 and 1wk fc negative long — needs base.
8	SHOE	BUY PULLBACK	5.0	Cheap (PE 10.7, fwd 7.86) with 1wk fc +75.9% long and 21% short float — but limited timeframe data available.
9	NXTC	WAIT	4.9	Just ran +180% on 21-bar and merger-announced (Avere); RSI 68.86 says chase — wait for post-deal digestion.
10	GLMD	WAIT	4.5	Positive Aramchol pipeline news and 1d fc +50/+107/+124%, but $4.2M cap makes 1wk fc of +1299% pure noise; deep loss-maker.
11	BESS	WAIT	4.3	At 0% of range with big forecasts, but -32% recent 1h drawdown reflects real breakdown; utility narrative unproven.
12	DRMA	WAIT	4.1	Weekly forecast of +24,865% is clearly an outlier; $5M micro-cap with ROE -103.58% — do not size.
13	TGEN	WAIT	4.0	Order backlog headline is positive and 1d fc +38%, but 1wk fc collapses to -52% long — no trend agreement.
14	AKTX	WAIT	3.7	Prospectus filed July 2 for resale of 6M ADSs/480B ordinary shares — dilution overhang blocks any long thesis.
15	QNTM	WAIT	3.6	1d fc +88% mid but ROE -984%, debtEq 1.45 — pure biotech lottery, size accordingly if at all.
16	MBRX	WAIT	3.4	Interim MIRACLE trial data 'fell short of significance' June 30 (-25% stock) — technical bounce not a fundamental fix.
17	LTRN	WAIT	3.4	ZetaOmics launch is positive but -32% drawdown at 0% of daily range with muted forecasts; needs base.
18	BCDA	WAIT	3.3	Near-term bullish 1.0 and 1wk fc +171%, but ROE -950% and sales YoY -100% — thesis is pure speculation.
19	EVGN	WAIT	3.2	1h/4h at 100% of range with RSI 63.96 — already ran on AI drug-discovery headlines; wait for pullback.
20	DARE	WAIT	2.9	Mixed forecasts (1d fc_short -2.9%) with debtEq 9.84 and profit margin -1038% — no urgency to buy.
21	RGNT	WAIT	2.7	European approval catalyst but bullish_prob is null and -52% 21-bar drawdown; no confirmed trend.
22	XTLB	WAIT	2.6	1h/4h forecasts negative (-16.24%/-9.08%) despite long-dated bullishness — near-term tape says wait.
23	YCBD	WAIT	2.5	$6M cap, bullish_prob 0.6, forecasts modest — Mexcor partnership is minor news; not enough edge.
24	LUCY	AVOID	2.3	Warrant exercise for $3M gross proceeds July 8 = active dilution; -45.79% 1h drawdown says pain not done.
25	BTCT	AVOID	2.1	Private placement announced July 9 — direct dilution overhang, 29.7% short float reflects the concern.
26	VEEE	AVOID	1.9	Already up 609% on 21-bar with RSI 75.94 at 100% of range — chasing a merger pop, not investing.
27	WW	AVOID	1.8	bullish_prob null, debtEq 1.76, sales YoY -9.61%; single-timeframe data is not enough conviction.
28	USBC	AVOID	1.5	bullish_prob only 0.6, 1d fc negative (-22/-51/-10%), targetUpside 11,664% is a data error — avoid.
29	IPWR	AVOID	1.3	Filed prospectus July 10 for up to $75M of common/preferred/warrants — textbook dilution setup.
30	PRSO	AVOID	1.1	ELOC signed with Roth for up to $25M on June 30 — continuous dilution machine, no long thesis works.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord